 |
H-016670 |
Xanomeline oxalate
CAS NO.：141064-23-5 |
 |
H-016671 |
methyl 3-chloro-5-(methylamino)picolinate
CAS NO.：1256835-56-9 |
 |
H-016673 |
1-(1-methyl-1H-imidazol-5-yl)ethanone-CAS# 20970-50-7
CAS NO.：20970-50-7 |
 |
H-016674 |
2-{[6-(chloromethyl)pyridin-2-yl]methyl}-2,3-dihydro-1H-isoindole-1,3-dione
CAS NO.：628308-52-1 |
 |
H-016677 |
(3-Methoxypyridin-4-yl)methanamine
CAS NO.：909895-75-6 |
 |
H-016678 |
2,3-dihydroxyterephthalaldehyde
CAS NO.：148063-59-6 |
S3)%3dC3C(Br)%3dCN1) |
H-016680 |
7-bromo-2-phenylthieno[3,2-c]pyridin-4(5H)-one
CAS NO.：690636-04-5 |
C2%3dC1C%3dC(C3%3dCC%3dCC%3dC3)S2) |
H-016681 |
4-chloro-2-phenylthieno[3,2-c]pyridine-7-carbonitrile
CAS NO.：1361197-82-1 |
 |
H-016685 |
3,4-dihydro-1H-carbazol-2(9H)-one
CAS NO.：40429-00-3 |
C%3dC2OC)C%3dC1) |
H-016686 |
4-((6-chloropyridin-3-yl)methoxy)-3-methoxybenzaldehyde
CAS NO.：860644-64-0 |
(C)C(C)(C)O2)%3dCC(F)%3dC1F) |
H-016687 |
2,3-difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
CAS NO.：1220219-43-1 |
C(C)(C)OB(C2%3dCC(C(C)(C)C)%3dNC%3dC2)O1) |
H-016688 |
2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS NO.：1627722-65-9 |
 |
H-016689 |
2-amino-N-(2-oxoazepan-3-yl)benzamide
CAS NO.：159970-38-4 |
%3dCC1%3dNC3%3dC2CCCC3)O) |
H-016691 |
9-chloro-5,6,7,8-tetrahydroacridine-3-carboxylic acid
CAS NO.：902586-59-8 |
ccn2C(%3dO)OC(C)(C)C) |
H-016692 |
tert-butyl 5-cyano-1H-pyrrolo[3,2-b]pyridine-1-carboxylate
CAS NO.：1364663-38-6 |
C(%2fC%3dC%2fC3%3dNN%3dNN3)%3dCN2) |
H-016693 |
(E)-3-(2-(1H-tetrazol-5-yl)vinyl)-6-fluoro-1H-indole
CAS NO.：1316695-35-8 |
 |
H-016696 |
(2-bromo-6-nitrophenoxy)(tert-butyl)dimethylsilane
CAS NO.：877161-00-7 |
COC2CCC2) |
H-016698 |
benzyl 2-cyclobutoxyacetate
CAS NO.：1364663-26-2 |
 |
H-016699 |
Finafloxacin Hydrochloride
CAS NO.：209342-41-6 |
 |
H-016700 |
methyl 2,5-dicyanobenzoate
CAS NO.：714237-94-2 |
 |
H-016701 |
6-methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine
CAS NO.：1000340-19-1 |
